Proteomics

Dataset Information

0

The C-terminal end of engineered albumin variants and fusion proteins after exposure to carboxypeptidase A


ABSTRACT: Albumin has a long plasma half-life due to engagement of the neonatal Fc receptor (FcRn), which prevents intracellular degradation. However, its C-terminal end can be cleaved by carboxypeptidase A, and removal of the last leucine residue (L585) weakens receptor binding, reducing its half-life from 20 days to 3.5 days in humans. This biology is important to consider when designing human albumin-fused biologics. Here, we explore engineering strategies to secure favorable FcRn binding and pharmacokinetic properties, and we use LC-MS/MS to analyze the amino acid sequence of the C-terminal end of engineered albumin variants and albumin fusion proteins, following incubation with or without carboxypeptidase A.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human) Mus Musculus (mouse)

SUBMITTER: Ingrid Maria Erika Ekman Stensland  

LAB HEAD: Tuula A. Nyman

PROVIDER: PXD063561 | Pride | 2025-05-19

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
LC-MS_files_exp1.zip Other
LC-MS_files_exp2.zip Other
mqpar_exp1.xml Xml
mqpar_exp2.xml Xml
txt_exp1.zip Other
Items per page:
1 - 5 of 6

Similar Datasets

2017-11-29 | E-MTAB-5297 | biostudies-arrayexpress
2017-11-29 | E-MTAB-5299 | biostudies-arrayexpress
2010-05-19 | PRD000228 | Pride
2020-10-27 | GSE160105 | GEO
2024-09-02 | BIOMD0000000546 | BioModels
2023-12-14 | GSE249471 | GEO
| PRJNA454496 | ENA
| PRJNA950409 | ENA
2024-11-04 | PXD044960 | Pride
2024-09-02 | BIOMD0000000916 | BioModels